CivicaScript, a nonprofit company dedicated to bringing low-cost generic medicines to US patients, announces the availability of dimethyl fumarate delayed-release capsules. Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS) in adults. CivicaScript will offer dimethyl fumarate 240 mg capsules for sale to pharmacies in units of one bottle of 60 capsules.